GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Entero Healthcare Solutions Ltd (BOM:544122) » Definitions » Altman Z-Score

Entero Healthcare Solutions (BOM:544122) Altman Z-Score : 7.08 (As of Mar. 04, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Entero Healthcare Solutions Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 7.19 is strong.

Entero Healthcare Solutions has a Altman Z-Score of 7.08, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Entero Healthcare Solutions's Altman Z-Score or its related term are showing as below:

BOM:544122' s Altman Z-Score Range Over the Past 10 Years
Min: 6.16   Med: 6.16   Max: 7.19
Current: 7.19

During the past 4 years, Entero Healthcare Solutions's highest Altman Z-Score was 7.19. The lowest was 6.16. And the median was 6.16.


Entero Healthcare Solutions Altman Z-Score Historical Data

The historical data trend for Entero Healthcare Solutions's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entero Healthcare Solutions Altman Z-Score Chart

Entero Healthcare Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Altman Z-Score
- - - 6.16

Entero Healthcare Solutions Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Altman Z-Score Get a 7-Day Free Trial - - - 6.16 -

Competitive Comparison of Entero Healthcare Solutions's Altman Z-Score

For the Medical Distribution subindustry, Entero Healthcare Solutions's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entero Healthcare Solutions's Altman Z-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Entero Healthcare Solutions's Altman Z-Score falls into.



Entero Healthcare Solutions Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Entero Healthcare Solutions's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.6009+1.4*-0.0144+3.3*0.041+0.6*7.6442+1.0*1.6581
=7.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2024:
Total Assets was ₹23,450 Mil.
Total Current Assets was ₹20,110 Mil.
Total Current Liabilities was ₹6,019 Mil.
Retained Earnings was ₹-338 Mil.
Pre-Tax Income was ₹356 Mil.
Interest Expense was ₹-605 Mil.
Revenue was ₹38,882 Mil.
Market Cap (Today) was ₹53,784 Mil.
Total Liabilities was ₹7,036 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(20109.75 - 6019.44)/23449.75
=0.6009

X2=Retained Earnings/Total Assets
=-338.07/23449.75
=-0.0144

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(355.55 - -604.82)/23449.75
=0.041

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=53784.227/7035.91
=7.6442

X5=Revenue/Total Assets
=38881.63/23449.75
=1.6581

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Entero Healthcare Solutions has a Altman Z-Score of 7.08 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Entero Healthcare Solutions  (BOM:544122) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Entero Healthcare Solutions Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Entero Healthcare Solutions's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Entero Healthcare Solutions Business Description

Traded in Other Exchanges
Address
Bandra Kurla Complex, Trade Centre, Unit No. 605 & 606, 6th Floor, Bandra East, Mumbai, MH, IND, 400051
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.

Entero Healthcare Solutions Headlines

No Headlines